Director/PDMR Shareholding

Summary by AI ^BETAClose X

Geiger Counter Limited announced that its Chairman, Gary Clark, subscribed for 50,020 Ordinary Shares for £18,607, and Non-Executive Director James Leahy subscribed for 22,838 Ordinary Shares for £8,496, totaling 72,858 new shares for £27,103. These director subscriptions are considered related party transactions, with the directors believing the terms are fair and reasonable for shareholders. Following these subscriptions, the directors will hold a combined total of 437,154 Ordinary Shares.

Disclaimer*

Geiger Counter Ltd

12 May 2026

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED

Geiger Counter Limited (or the "Company")

12 May 2026

Director Subscriptions

Further to the announcement by the Company on 30 March 2026, in respect of the right to subscribe for Ordinary Shares in the Company, the following directors have subscribed for the following Subscription Shares:

Director	Position	Amount (£) subscribed for	Number of Subscription Shares subscribed for	Total Ordinary Shares held on Admission
Gary Clark	Chairman	18,607	50,020	300,122
James Leahy	Non Executive Director	8,496	22,838	137,032
Total		27,103	72,858	437,154

Related party transactions

The Director subscriptions set out in the table above are each related party transactions. The Directors consider that the terms of the Director's subscriptions are fair and reasonable insofar as shareholders are concerned.

Enquiries

Manulife \| CQS Investment Management	Craig Cleland	T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited	Tunga Chigovanyika (Corporate Finance)	T: +44 (0) 20 7397 1915
	Daniel Balabanoff / Pauline Tribe (Sales)	T: +44 (0) 20 7220 0500
Summit Fund Services Jersey Limited	Christopher Foulds	T:+44 (0) 1534 825 259

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END